Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: Can the initial promising results be reproduced?

European Radiology

Volumn 24, Issue 2, 2014, Pages 371-379

  Heijnen, Luc A ^a,e   Lambregts, Doenja M J ^a   Martens, Milou H ^a,e   Maas, Monique ^a   Bakers, Frans C H ^a   Cappendijk, Vincent C ^b   Oliveira, Pedro ^c   Lammering, Guido ^d,e   Riedl, Robert G ^a   Beets, Geerard L ^a,e   Beets Tan, Regina G H ^a,e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^d MAASTRO CLINIC   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Gadofosveset trisodium; Lymph nodes; Magnetic resonance imaging; Neoadjuvant therapy; Rectal neoplasms

Indexed keywords

GADOFOSVESET;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HUMAN TISSUE; LEARNING CURVE; MAJOR CLINICAL STUDY; MICROMETASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFORMANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGANOMETALLIC COMPOUNDS; PELVIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84893208823     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-3016-6     Document Type: Article

References (32)

1. Habr-Gama A, Perez RO, Proscurshim I et al (2006) Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 10:1319-1328
2. Lezoche G, Baldarelli M, Guerrieri M et al (2008) A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 22:352-358
3. Maas M, Beets-Tan RG, Lambregts DM et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633-4640
4. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology 232:773-783
5. Brown G, Richards CJ, Bourne MW et al (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227:371-377
6. Dworak O (1989) Number and size of lymph nodes and node metastases in rectal carcinomas. Surg Endosc 3:96-99
7. Kim J, Beets G, Kim M-J, Kessels A, Beets-Tan R (2004) High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol 52:78-83
8. Wang C, Zhou Z, Wang Z et al (2005) Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum. Langenbecks Arch Surg 390:312-318
9. Fischbein NJ, Noworolski SM, Henry RG, Kaplan MJ, Dillon WP, Nelson SJ (2003) Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 24:301-311
10. Jansen JF, Schoder H, Lee NY et al (2010) Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys 77:1403-1410
11. Kvistad KA, Rydland J, Smethurst HB, Lundgren S, Fjosne HE, Haraldseth O (2000) Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 10:1464-1471
12. Lambregts DM, Maas M, Riedl RG et al (2011) Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study. Eur Radiol 21:265-273
13. Mir N, Sohaib SA, Collins D, Koh DM (2011) Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. J Med Imaging Radiat Oncol 54:358-364
14. Mizukami Y, Ueda S, Mizumoto A et al (2011) Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg 35:895-899
15. Lambregts DM, Beets GL, Maas M et al (2011) Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg 253:539-545
16. Herborn CU, Lauenstein TC, Vogt FM, Lauffer RB, Debatin JF, Ruehm SG (2002) Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model. AJR Am J Roentgenol 179:1567-1572
17. Lahaye MJ, Beets GL, Engelen SME (2009) Gadofosveset Trisodium (Vasovist®) enhanced MR lymph node detection: initial observations. Open Magn Reson J 2:1-5
18. Lahaye MJ, Engelen SM, Kessels AG et al (2008) USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology 246:804-811
19. Will O, Purkayastha S, Chan C et al (2006) Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 7:52-60
20. Valentini V, Coco C, Gambacorta M, Barba M, Meldolesi E (2010) Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). Acta Chir Iugosl 57:9-16
21. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E et al (2001) No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19:1976-1984
22. Hatfield P, Hingorani M, Radhakrishna G et al (2009) Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol 92:210-214
23. Radu C, Berglund A, Pahlman L, Glimelius B (2008) Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study. Radiother Oncol 87:343-349
24. Rödel C, Trojan J, Bechstein W, Woeste G (2012) Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: how and who should be treated? Dig Dis 30:102-108
25. Lambregts D, Heijnen L, Maas M et al (2013) Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria. Abdom Imaging 38:720-727
26. Cohen J (1986) Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70:213-220
27. Perez R, Pereira D, Proscurshim I et al (2009) Lymph node size in rectal cancer following neoadjuvant chemoradiation - can we rely on radiologic nodal staging after chemoradiation? Dis Colon Rectum 52:1278-1284
28. Habr-Gama A, Perez RO, Proscurshim I et al (2008) Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 71:1181-1188
29. Kerr SF, Norton S, Glynne-Jones R (2008) Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg 95:1534-1540
30. Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ (2007) Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 9:563-571
31. Perez RO, Habr-Gama A, Nishida Arazawa ST et al (2005) Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy. Int J Colorectal Dis 20:434-439
32. Wolthuis AM, Penninckx F, Haustermans K et al (2012) Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome. Ann Surg Oncol 19:2833-2841